ONCR 021
Alternative Names: ONCR-021Latest Information Update: 28 Jun 2025
At a glance
- Originator Oncorus
- Class Antineoplastics; Immunotherapies; Oncolytic viruses
- Mechanism of Action Cell death stimulants; Immunologic cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Liver cancer; Malignant melanoma; Non-small cell lung cancer; Renal cell carcinoma
Most Recent Events
- 28 Jun 2025 No recent reports of development identified for preclinical development in Liver-cancer in United Kingdom (IV)
- 28 Jun 2025 No recent reports of development identified for preclinical development in Malignant-melanoma in United Kingdom (IV)
- 28 Jun 2025 No recent reports of development identified for preclinical development in Non-small-cell-lung-cancer in United Kingdom (IV)